Inozyme Pharma Inc. (INZY) PT Lowered to $14 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Tazeen Ahmad lowered the price target on Inozyme Pharma Inc. (NASDAQ: INZY) to $14.00 (from $16.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
